Literature DB >> 29866704

Serum antigliadin antibodies in cerebellar ataxias: a systematic review and meta-analysis.

Chi-Ying Lin1, Min-Jung Wang2, Winona Tse1, Rachel Pinotti3, Armin Alaedini4, Peter H R Green4, Sheng-Han Kuo5.   

Abstract

BACKGROUND: Gluten sensitivity refers to prominent immunological responses to gluten, usually in conjunction with elevated levels of serum antigliadin antibody (AGA). The association between AGA and cerebellar ataxias has been inconsistently reported.
METHODS: We performed a systematic literature search and a meta-analysis to study the weighted pooled OR of idiopathic cerebellar ataxia (IDCA) cases to controls or to hereditary ataxia (HA) for AGA seropositivity using fixed effect model.
RESULTS: Eleven studies were included, with a total of 847 IDCA cases, 1654 controls and 445 HA cases. IDCA cases had fourfold higher odds than controls (OR 4.28, 95% CI 3.10 to 5.90) and twofold higher odds than HA cases (OR 2.23, 95% CI 1.45 to 3.44) of having AGA seropositivity. Sensitivity analysis excluding the most weighted study, which accounted for 69% of the total weight, still showed similar associations (IDCA vs controls, OR 3.18, 95% CI 1.79 to 5.67 and IDCA vs HA, OR 1.72, 95% CI 1.03 to 2.86, respectively). The subgroup analysis showed that, when compared with controls, IDCA cases of both East Asian and Western countries had approximately threefold to fourfold higher odds to have AGA seropositivity (OR 3.41, 95% CI 1.67 to 6.97 and OR 4.53, 95% CI 3.16 to 6.49, respectively), suggesting the lack of ethnic heterogeneity. The odds of AGA seropositivity for HA cases was not significantly higher than controls (OR 1.41, 95% CI 0.82 to 2.44).
CONCLUSION: Our study indicates the association between AGA and IDCA, across different geographic regions. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29866704      PMCID: PMC6231948          DOI: 10.1136/jnnp-2018-318215

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  The neurologic significance of celiac disease biomarkers.

Authors:  Andrew McKeon; Vanda A Lennon; Sean J Pittock; Thomas J Kryzer; Joseph Murray
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

2.  Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.

Authors:  R Sivera; N Martín; I Boscá; T Sevilla; N Muelas; I Azorín; J J Vílchez; M Bolonio; E Donat; C Ribes-Koninckx; L Bataller
Journal:  J Neurol       Date:  2011-10-08       Impact factor: 4.849

3.  Gluten sensitivity in sporadic and hereditary cerebellar ataxia.

Authors:  K O Bushara; S U Goebel; H Shill; L G Goldfarb; M Hallett
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

4.  Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia.

Authors:  Masafumi Ihara; Fumi Makino; Hideyuki Sawada; Takahiro Mezaki; Kotaro Mizutani; Hiroshi Nakase; Makoto Matsui; Hidekazu Tomimoto; Shun Shimohama
Journal:  Intern Med       Date:  2006-03-01       Impact factor: 1.271

Review 5.  The natural history of gluten sensitivity: defining, refining and re-defining.

Authors:  M N Marsh
Journal:  QJM       Date:  1995-01

Review 6.  Sporadic cerebellar ataxia associated with gluten sensitivity.

Authors:  K Bürk; S Bösch; C A Müller; A Melms; C Zühlke; M Stern; I Besenthal; M Skalej; P Ruck; S Ferber; T Klockgether; J Dichgans
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

7.  Coeliac disease in patients with cerebellar ataxia of unknown origin.

Authors:  L K Luostarinen; P O Collin; M J Peräaho; M J Mäki; T A Pirttilä
Journal:  Ann Med       Date:  2001-09       Impact factor: 4.709

8.  Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxia.

Authors:  Roberto Fancellu; Davide Pareyson; Elena Corsini; Ettore Salsano; Matilde Laurà; Gaetano Bernardi; Carlo Antozzi; Francesca Andreetta; Maurizio Colecchia; Stefano Di Donato; Caterina Mariotti
Journal:  Eur Neurol       Date:  2009-09-26       Impact factor: 1.710

Review 9.  Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis.

Authors:  Pietro Amedeo Modesti; Gianpaolo Reboldi; Francesco P Cappuccio; Charles Agyemang; Giuseppe Remuzzi; Stefano Rapi; Eleonora Perruolo; Gianfranco Parati
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

Review 10.  Guidelines for treatment of immune-mediated cerebellar ataxias.

Authors:  Hiroshi Mitoma; Marios Hadjivassiliou; Jérôme Honnorat
Journal:  Cerebellum Ataxias       Date:  2015-11-10
View more
  6 in total

Review 1.  Ataxia.

Authors:  Sheng-Han Kuo
Journal:  Continuum (Minneap Minn)       Date:  2019-08

2.  Sporadic adult-onset spinocerebellar ataxias : Reply: Degenerative and acquired sporadic adult-onset ataxia https://doi.org/10.1007/s10072-019-03856-w.

Authors:  Hélio A Ghizoni Teive; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Neurol Sci       Date:  2019-06-28       Impact factor: 3.307

Review 3.  Autoantibodies in the Extraintestinal Manifestations of Celiac Disease.

Authors:  Xuechen B Yu; Melanie Uhde; Peter H Green; Armin Alaedini
Journal:  Nutrients       Date:  2018-08-20       Impact factor: 5.717

Review 4.  Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article.

Authors:  Dina Osman; Seemeen Umar; Humayun Muhammad; Esmaeil Nikfekr; Kamran Rostami; Sauid Ishaq
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

Review 5.  Who to screen and how to screen for celiac disease.

Authors:  Prashant Singh; Achintya Dinesh Singh; Vineet Ahuja; Govind K Makharia
Journal:  World J Gastroenterol       Date:  2022-08-28       Impact factor: 5.374

Review 6.  A Breakdown of Immune Tolerance in the Cerebellum.

Authors:  Christiane S Hampe; Hiroshi Mitoma
Journal:  Brain Sci       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.